Prediction and mitigation of mutation threats to COVID-19 vaccines and antibody therapies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Prediction and mitigation of mutation threats to COVID-19 vaccines and antibody therapies

Published:2021 Issue:20 Volume:12 Page:6929-6948
ISSN:2041-6520
Container-title:Chemical Science
language:en
Short-container-title:Chem. Sci.

Author:

Chen Jiahui¹²³,Gao Kaifu¹²³,Wang Rui¹²³^ORCID,Wei Guo-Wei¹²³⁴²^ORCID

Affiliation:

1. Department of Mathematics

2. Michigan State University

3. USA

4. Department of Electrical and Computer Engineering

Abstract

Antibody therapeutics and vaccines are among our last resort to end the raging COVID-19 pandemic.

Funder

National Aeronautics and Space Administration

National Institutes of Health

National Science Foundation

Michigan Economic Development Corporation

George Mason University

Bristol-Myers Squibb

Pfizer

Publisher

Royal Society of Chemistry (RSC)

Subject

General Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2021/SC/D1SC01203G

Reference89 articles.

1. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding

2. M. Day , Covid-19: four fifths of cases are asymptomatic, China figures indicate , 2020

3. Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections

4. Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preventing future zoonosis: SARS-CoV-2 mutations enhance human–animal cross-transmission;Computers in Biology and Medicine;2024-11

2. SARS-CoV-2 infectivity and antigenic evasion: spotlight on isolated Omicron sub-lineages;Frontiers in Medicine;2024-08-29

3. Influence of Mutations on Physicochemical Properties of Spike Proteins from Prototypical SARS-CoV-2 Variants of Concern Detected in Amazonian Countries;Microbiology Research;2024-07-27

4. Changing epidemiology of COVID-19: potential future impact on vaccines and vaccination strategies;Expert Review of Vaccines;2024-05-06

5. Reduced Viral Shedding Time in High-Risk COVID-19 Patients Infected by Omicron and Treated with Paxlovid: A Real-World Study from China;Infection and Drug Resistance;2024-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3